| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0004 |